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Microbes, Men, and Animals 
Dr. Charle11 Beruon (left) and Dr. Jon Palmer. 
Unlike gregarious human beings, animals do 
not hold conventions, and are therefore spared 
the discomfort� and death, visited upon some 
of the people who convened in Philadelphia in 
1976. As you probably recall, this was the 
infamous American Legion convention held at 
the stately Bellevue Stratford hotel and the 
disease outbreak brought about the demise of 
a Philadelphla landmark. Naturally, the mal· 
ady was quickly JabeUed "Legionaires Disease." 
Subsequently, there have been some well pub· 
licized outbreaks of this disease in other parts 
of the world, and the causative organism has 
been identified as Legion.ella pneumophilia. 
It now appears that animals may be carri· 
era of this organism, and Dr. Charles E. Ben· 
son has begun a screening study to determine 
whether this is true. Dr. Benson is associate 
professor ot microbiology in the School of 
Veterinary Medicine, whose laboratory is 
located at New Bolton Center. Dr. Benson has 
been involved in some basic studies on the 
cbarac"teristics of L. pneumophilia which is an 
organism that invades body cells. L. pneltl1W­
philia itselr has never been isolated from 
animals. but. antibodies, produced in response 
to the organism, have been detected. Dr. Ben­
son•s work is concerned with direct isolation of 
the bacterium, a difficult chore. The organism 
can be isolated from human beings where it 
causes an atypical pneumonia, and Dr. Benson 
has it growing in cell culture in his laboratory. 
Dr. Benson's quest for this organism in animals 
is iUustrative of one of his basic philosophies, 
to wit, "we only find what we look for." Des· 
pite some great strides, Dr. Benson points out 
that we are still on the frontier in our efforts 
to specifically identify bacteria that cause 
many iniectious diseases in animals. There are 
a number of clinical syndromes in animals "that 
appear to be of an infectious nature, but for 
which a causative organism has not been iden· 
tilled. With this in mind, Dr. Benson and var­
ious clinicians at New Bohon Center have 
teamed together in the hope of gaining a bet· 
ter understanding of the pathogenesis of cer· 
tain of these perplexing syndromes. The clini­
cians with whom he has been working most 
closely are Dr. Robert Whitlock, Dr. Robert 
Dyer, and Dr. Jon Palmer. Prior to Dr. Ben· 
son's arrival at New Bolton Center in January 
1961, this sort of cooperative effort in the 
study of infectious diseases had been ne· 
glected. Dr. Whitlock, who is associate 
professor of medicine and chief of medical 
services at New Bolton Center is quite enthu­
siastic about the future of this field. 
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Another major research interest of Dr. Ben· 
son is the study of the organism, Salmonella. 
This is a pathogen t.hat has long been the 
plague of animals and humans. Interestingly, it 
was first discovered by a veterinarian, Dr. 
DarueJ E. Salmon, who was the first Chief of 
the Federal Bureau of Animal Industry. One 
problem in any study of Salmonella is that 
there are over 1,200 strains of t.he organism. 
WhiJe certain strains have been identified as 
the cause of the disease in animals known as 
salmone1Josis, it is possible that other, uniderr 
tified strains may also be involved. One of the 
objects of Dr. Ben11on's work will be to attempt 
to define mechanisms of pathogenesis. The 
particular strain now most commonly asso­
ciated with colitis in horses is Salmonella 
typhimurium. The common clinical signs are 
hyperthennia, diarrhea, co.bcy pain, and occa­
sionally a rapidly developing septicemia. One 
characteristic of equine salmonellosis is that it 
strikes horses that are in stressful situations, 
includjng transport, weaning, worming, or any 
other situation that lowers resistance. Surgery 
may predispose horses to salmonellosis, and 
one aspect of the work of Dra. Benson and 
Palmer is to examine horses post-surgically for 
the presence of Salmonella. Salmonellosis is 
highly contagious at the local level; it can 
become entrenc.�hed on a particular farm. 
Horses with salmonellosis at New Bolton Cen· 
ter are placed in isolation. 
Dr. Benson states that some SalmoneUa 
strains have the capability of producing to.x.im. 
This is related to the genetic make-up of a 
particular organism. Honles with toxemia. 
associated with salmonellosis, have been 
observed at New &Lton Center, and the se.a.r.:h 
£or strains that produce this phenomena will 
be part of the Benson/Palmer study. 
In the past ten years there has been an 
increase in the incidence of Salmonella infec· 
tions in both humans and animals. Recently 
there have been outbreaks of the disease in 
humans foJJowing t.he consumption of cooked 
beef. One problem in the spread of salmonel­
losis is the fact that most species, including 
humans, can act tLs carriers of the bacteria 
without exhibiting overt clinical signs. It is 
estimated that at least ten percent of the horse 
population are carriers of Salmonella. 
Diagnosis of salmonellosis is based upon 
identification of or�anisms in fecal culture. 
This may he difficult in carrier animals, and 
Dr. Beru;on hopes to improve diagnostic 
methods. 
A cooperative study in which Dr. Benson is 
involved witb Dr. Dyer, concerns the etiology 
of "shipping fever,. in cattle and horses. Dr. 
Benson is also conducting basic research on 
metaboli� pathways in Salmonella and other 
organisms. While he is relatively new to the 
faculty of the School of Veterinary Medicine, 
Dr. Benson has been at the University of Penn· 
sylvania since 1975, with the School of Allied 
Medical Professions. In addition to research he 
teaches in the core and elective portions of the 
veterinary curriculum, and is administrator of 
the clinical laboratory at New Bolton Center. 
Canine 
Epilepsy 
Epilepsy is one of the most common canine 
neurological complaints, yet control of sei­
zures in dogs remains a difficult, frustrating, 
and often unrewarding task for veterinarian, 
owner, and patient. In an effort to remedy 
this situation. t••e Vetednary Hospital of the 
University of Pennsylvania has recently insti· 
tuted an epilepsy foundation for dogs called 
the Canine Epilepsy Service under the direc· 
torship of Or. George C. Farnbach, V.M.D., 
Ph.D., assi�tant professor of neurology. This 
canine epilepsy center has the ambitious 
goals of improving the control of seizures iu 
epileptic dogs and, if possible, eliminating 
seizures altogether through a cooperative 
effort involving pets, their owners, their 
locaJ veterinarians. and the facilities of the 
Canine Epilepsy Service (CES). 
Dogs, like people, suffer from epilepsy of 
varying inten5ities and types. Like the physi­
cian, a veterinarian is generally forced to 
attempt to control epilepsy through the use 
of anticonvulsant drugs. The control of seiz­
ures in humans is tnore often successful than 
it is in dogs because considerably more 
information about the use and effectiveness 
of anticonvulsant drugs in humans is avail­
able to the physician. The process of control­
ling human �:�ei.zures has been considerably 
advanced by the study of large numbers of 
epileptic patients on a variety of treatment 
regimens, which was made possible by cen· 
tralized epilepsy study groups. These groups 
have deveJoped a wealth of knowledge about 
the efficacy of $pecHic drugs, the blood levels 
required to control seizures. and the toxic 
and long-term effects of these drugs. Modern 
technology now permi1s relatively inexpen­
sive monitoring of serum drug leve]s, ena· 
bling the physician to adjust or switch anti· 
convulsants for maximum effect and 
minimum toxicity baAed on the knowledge of 
each drug and the individual patient's blood 
levels. No such body of knowledge exists in 
veterinary medicine, leaving the practitioner 
to determine the appropriate anticonvulsant 
for the patient on a limited and basically 
blind triaJ-and-error basis. This can be a 
costly and frustrating process. 
"There are a variety of drugs and drug 
combinations which can be used in control 
protocols, yet accurate information about the 
effecti\•e and toxic blood levels of these 
drugs or about their long-term side effects in 
the dog does not exist, .. Farnbach explained. 
�At the CES we hope to collect this kind of 
information over u Lon� period of time. Our 
goal is to monitor at least 1,000 dogs for at 
least three yearM." 
To illustrate the importance of drug 
information, F'arnbach cited Dilantin, a drug 
commonly used in both humans and dogs to 
control seizures. uln humans, DiJantin is 
effective in many patients, but to control 
seizures, blood levels above 10 ug/ml are 
required. An effective dose for an adult 
human is about 300 mg/day. We do not know 
Service 
if Dilantin is effective in the dog, but we do 
know that the dog metaboli2les Dilantin 
about 10 times faster than humans. In over 
100 serum diJantin assays sent in from epi­
leptic dogs, none showed more Dilantin than 
7.2 ug/ml and none of the dogs were con­
trolled. Three hundred mg/day might he an 
effective dose for a small dog like a Chihua· 
bua, but a German Shepherd would need 
about 3,000 mg/day to reach 10 ug/ml in its 
blood. And we don't know yet whether that 
would be effective." 
In humans, where effective blood levels 
of Dilantin are known and patient blood lev­
els can be monitored, the daily dosage can 
easily be adjusted to fit the metabolic char­
acteristics of each individual patient. If a 
human patient has adequate blood levels of 
Dilantin but continues to seizure, it becomes 
immediately clear that a new drug and not a 
new dose should be tried. The veterinarian 
however, without blood level measurements, 
must arbitnrily decide when to stop increas­
ing dosages and change to or add different 
drugs. To improve the techniques in veteri­
nary seizure control. the Epilepsy Service 
utilizes information collected from three 
sources: 1) the pet owner, 2) the local veteri­
narian, and 3) the routine monitoring of 
blood levels of anticonvulsant medications in 
epileptic animals. 
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� nyone with a loved one-pet or human-that suffers 
from epilepsy has serious medical and emotional problems 
to face. Ira the past, we (the reterinarian and pet owners) 
hat.'e faced thern alone and basically in the dark. If we can 
get together both people and information we tvill not be 
alone and� hopefully, the future will be brighter." 
A computer-based data management facil­
ity has been established to carefully record 
and monitor each patient. Initial informa· 
tion about each patient is recorded as their 
names are sent to the registry by the local 
veterinarian. Pet owners are sent explanatory 
litemture and forms to a·ecord the character­
istics of each subsequent seizure. These 
forms are filled in as seizures occur and are 
mailed to the CES in order to monitor both 
frequency and severity of each pet•s seizure 
pattern. When an anticonvulsant drug pro­
tocol is started by the local veterinarian, the 
name of the drug or drugs and their dosages 
and blood samples are sent to the CES. The 
name and dosage of each drug and the cor· 
responding serum level is added to the data 
base for each individual patient. In this way, 
changes in seizure patterns (or Lack thereof) 
can be correlated with serum drug levels and 
dose patterns in hundreds of individual 
animals and the efficacy and toxicity of drug 
protocols can be evaluated. 
The computerized data management sys· 
tern has been developed by Dr. Farnbach 
specifically for the CES. Drug level mea· 
surements ue made nsing the EMIT system 
which has been validated for use with dog 
serum by the SYVA Co. of Palo Alto, CA in 
conjunction with the Canine Epilepsy Ser· 
vice. This system represents a technological 
advance which has proven advantageous in 
monitoring human anticon,·ulsant therapy 
and which will be cost-effective in monitor­
ing veterinary anticonvulsant therapy. 
''Computers and high technology are not 
the answer," Farnbach emphasized ... What is 
needed is a massive cooperative effort 
between animal lovers, veterinarians and 
research workers. Anyone with a loved one­
pet or human-that suffers from epilepsy has 
serious medical and emotional problems to 
face. In the past, we (the veterinarians and 
pet owners) have faced them alone and basi­
cally in the dark. If we can get together both 
people and information we will not be alone 
and, hopefully, the future will be brighter." 
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Owners of epileptic dogs are a very 
important part of the program. They not 
only provide the veterinarian with the initial 
information but they also provide the CES 
with continuing information about the dog 
and its improvement or the nature and fre· 
quency of recurring seizures. The CES pro­
vides mote than record keeping for the 
owner. It provides support and information 
and answers questions on both an individual 
basis and through a Newsletter which will he 
published shortly. In this way owners can see 
that they are not alone and that their pet's 
pTOblems are not unique. Further, the ques­
tions and observations of the owners may 
provide clues about seizure patterns and 
triggers wtllch may have been previously 
missed and ignored. 
Participating veterinarians. also play an 
obviously important role. Their observations 
regarding efficacy, toxicity and long·term side 
effects are essential to the development of 
more rational drug protocols. In return for 
their participation, veterinarians receive sev· 
eral benefits: serum drug leve] measurements 
are provided inexpensively; each animaPs 
seizure and drug history is immediately 
avaHable by computer for consultation with 
the staff of CES, if they desire; and new con· 
cepts regarding seizure control are dissemi· 
nated as soon as thev are extracted from the 
collected re<'.orda of 
·
all dogs in the program. 
A Veterinary Newsletter is also being pub­
lished for professional members of the 
Canine Epilepsy Service. 
The services of the Canine Epilepsy Ser­
vice are available to aiJ pet owners free of 
charge. Veterinarians are asked to make a 
small annual contribution to cover the costs 
of publications and computer maintenance. 
Serum drug level measurements are provided 
at cost for member veterinarians. The medi· 
cal data (but not the personal data) are 
available to any legitimate research organiza­
tion wishing to use them in medical research. 
Those interested in more detailed informa­
tion or in. contributing to the program 
should contact George C. Farnbach, V.M.D., 
Ph.D., Director, Canine Epilepsy Service, 
School of Veterinary Medicine, University of 
Pennsylvania, 3800 Spruce Street, Philadel­
phia, Pa. 19104 . 
